Pharmacist-guided pre-emptive pharmacogenetic testing in antidepressant therapy (PrePGx): study protocol for an open-label, randomized controlled trial

Pharmacist-guided pre-emptive pharmacogenetic testing in antidepressant therapy (PrePGx): study protocol for an open-label, randomized controlled trial

Abstract Background It is known that only 50% of patients diagnosed with major depressive disorders (MDD) respond to the first-line antidepressant treatment. Accordingly, there is a need to improve response rates to reduce healthcare costs and patient suffering. One approach to increase rates of tre...

Full description

Bibliographic Details
Main Authors: Céline K. Stäuble, Markus L. Lampert, Samuel Allemann, Martin Hatzinger, Kurt E. Hersberger, Henriette E. Meyer zu Schwabedissen, Christian Imboden, Thorsten Mikoteit
Format: Article
Language:English
Published: BMC 2021-12-01
Series:Trials
Subjects:
Pharmacogenomics
Depression
Antidepressant
Pharmaceutical care
Psychiatry
Online Access:https://doi.org/10.1186/s13063-021-05724-5

Internet

https://doi.org/10.1186/s13063-021-05724-5

Similar Items